NCT00241189View on ClinicalTrials.gov

Rapamycin vs Methotrexate in Diffuse SSc

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Systemic Sclerosis
Interventions
DRUG

rapamycin

DRUG

methotrexate

Trial Locations (1)

90095-1670

Philip Clements, MD, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00241189 - Rapamycin vs Methotrexate in Diffuse SSc | Biotech Hunter | Biotech Hunter